Xinanuo Pharmaceutical Technology (Shanghai) Co., Ltd. is dedicated to the independent R&D and domestic substitution of high-end bioreactor systems. The company has established a full-process technology framework covering laboratory research, bench-scale development, pilot-scale validation, and industrial-scale production. Our core proprietary technologies encompass bioreactor structural design, control system integration, and online monitoring algorithms, with both hardware and software platforms achieving full independent control. We provide glass and stainless steel bioreactor equipment suitable for scientific research, process development, and pilot-scale scale-up in the biopharmaceutical field. Our solutions help biopharmaceutical companies improve production efficiency and process stability, driving the localization and intelligentization of the biomanufacturing industry.

Xinanuo bioreactor systems meet the stringent requirements for process stability and cleanliness in the R&D and production of blood products. Our glass and stainless steel series cover laboratory process exploration and pilot-scale industrialization scenarios, respectively. The CIP (Clean-in-Place) and SIP (Sterilize-in-Place) functions of our stainless steel bioreactors minimize contamination risks during blood product manufacturing, ensuring the safety of both raw materials and finished products. We provide blood product companies with comprehensive equipment solutions from laboratory to industrial production, empowering process optimization and capacity expansion in the blood products industry.

In response to the stringent requirements for clean environments, process continuity, and aseptic assurance in the R&D and production of human vaccines, Xinanuo offers stainless steel series bioreactors equipped with one-click CIP (Clean-in-Place) and SIP (Sterilize-in-Place) functions. These features effectively reduce manual operation intensity and contamination risks, ensuring the safety and stability of vaccine production processes. Meanwhile, our full-process technology framework supports equipment needs ranging from laboratory vaccine candidate screening to industrial-scale scale-up production. With our independently developed core technologies, we empower the human vaccine industry to conduct R&D and large-scale production efficiently and reliably.

To meet the demands for personalized and high-precision cultivation in the gene and cell therapy field, Xinanuo bioreactor systems leverage our independently developed core hardware and software platforms, combined with online monitoring algorithms, to achieve precise control and real-time monitoring of cell culture processes. They are well-suited for key process steps such as gene transfection and cell expansion. Our glass and stainless steel product series address laboratory-based fundamental research and pilot-scale scale-up needs, respectively. The CIP/SIP functions of our stainless steel products further ensure the sterility and consistency of cell therapy products. We provide advanced and reliable equipment support for the gene and cell therapy industry, facilitating the industrialization of personalized therapeutic technologies.

Xinanuo Pharmaceutical Technology's high-end bioreactor systems are also widely applicable in antibody drugs, recombinant protein drugs, synthetic biology, and other life sciences and biomanufacturing-related fields. Our full-process technology framework and independently developed intellectual property portfolio enable us to provide customized equipment solutions for clients across various market segments. We help biotech companies overcome critical equipment bottlenecks, achieve technological innovation and industrial upgrading, and jointly promote the high-quality development of the life sciences field.